Literature DB >> 20032420

Altered glucose metabolism during chemoradiation for head and neck cancer.

Nam P Nguyen1, Paul Vos, Vincent Vinh-Hung, Thomas L Borok, Suresh Dutta, Ulf Karlsson, Howard Lee, Tomas Martinez, Beng-Hoey Jo, Ly M Nguyen, Nga Nguyen, Sabah Sallah.   

Abstract

UNLABELLED: Platinum-based chemotherapy has been reported to induce diabetes and hyperosmolar coma in nondiabetic patients. The aim of the present study was to determine whether the administration of chemoradiation for head and neck carcinoma alters glucose metabolism during and after treatment. PATIENTS AND METHODS: Weekly nonfasting serum glucose level was obtained during treatment of one hundred and six patients with locally advanced head and neck cancer who underwent chemoradiationt.
RESULTS: For the 91 non-diabetic patients, mean serum glucose level measured 97.75 before and 102.1, 102, 104.1, 109.1, 109.7, 110.3, 109.8, 113.2, 107.7 and 104.3 mg/dl during weeks 1-10 of treatment respectively. Serum glucose level elevation reached statistical significance for weeks 5-8.
CONCLUSION: Chemoradiation for head and neck cancer may produce severe glucose metabolism alteration during treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032420

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Reactive-oxygen-species-mediated Cdc25C degradation results in differential antiproliferative activities of vanadate, tungstate, and molybdate in the PC-3 human prostate cancer cell line.

Authors:  Tong-Tong Liu; Yan-Jun Liu; Qin Wang; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2011-10-20       Impact factor: 3.358

2.  Chronic oral mucositis after radiotherapy to the head and neck: a new insight.

Authors:  Sharon Elad; Yehuda Zadik
Journal:  Support Care Cancer       Date:  2016-07-30       Impact factor: 3.603

3.  Chronic disease burden among cancer survivors in the California Behavioral Risk Factor Surveillance System, 2009-2010.

Authors:  Heather P Tarleton; Suzanne Ryan-Ibarra; Marta Induni
Journal:  J Cancer Surviv       Date:  2014-04-09       Impact factor: 4.442

4.  Early nutritional support in non-metastatic stage IV oral cavity cancer patients undergoing adjuvant concurrent chemoradiotherapy: analysis of treatment tolerance and outcome in an area endemic for betel quid chewing.

Authors:  Cheng-Hsu Wang; Hung-Ming Wang; Yi-Ping Pang; Kun-Yun Yeh
Journal:  Support Care Cancer       Date:  2011-05-20       Impact factor: 3.603

Review 5.  Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review.

Authors:  Zhi-Kai Zheng; Jiong-Liang Wang; Wen-Xuan Li; Tian-Qing Wu; Min-Shan Chen; Zhong-Guo Zhou
Journal:  Front Public Health       Date:  2022-06-16

Review 6.  Hazards and risks in oncology: radiation oncology.

Authors:  Thomas G Wendt
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

Review 7.  From obesity to diabetes and cancer: epidemiological links and role of therapies.

Authors:  Custodia García-Jiménez; María Gutiérrez-Salmerón; Ana Chocarro-Calvo; Jose Manuel García-Martinez; Angel Castaño; Antonio De la Vieja
Journal:  Br J Cancer       Date:  2016-02-23       Impact factor: 7.640

Review 8.  Cancer Biology and Prevention in Diabetes.

Authors:  Swayam Prakash Srivastava; Julie E Goodwin
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

9.  Ambient PM gross β-activity and glucose levels during pregnancy.

Authors:  Veronica A Wang; Tamarra James-Todd; Michele R Hacker; Karen E O'Brien; Blair J Wylie; Russ Hauser; Paige L Williams; Andrea Bellavia; Marlee Quinn; Thomas F McElrath; Stefania Papatheodorou
Journal:  Environ Health       Date:  2021-06-14       Impact factor: 5.984

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.